Artivion Inc - AORT Short-Term Debt to Capital

AORT (Artivion, Inc.) - company brandmark

The price trend illustrated in this chart reflects the dynamics of Artivion, Inc. (AORT), which focuses on the development of unique biomaterials and On-X stents. Management is expanding a global portfolio of high-tech solutions, and the indicator stands at 0.00. Revenues are driven by an aging population and patents, while high surgeon loyalty and strict FDA regulations ensure the stability of the market ecosystem.

AORT - CryoLife Short-Term Debt to Equity Ratio over the range 07/04/2022 - 11/01/2026
Brand item of Artivion

To assess the fundamental stability of Artivion, Inc. (AORT), it is essential to analyze the ratio of short-term liabilities to total equity, which measures the extent to which current liquidity depends on internal funds. The stability of the short-term debt-to-equity ratio confirms a balanced financial policy, ensuring predictable debt service while implementing capital-intensive R&D projects to develop advanced cardiology implants and cryopreservation systems.

Main competitors

Short-Term Debt to Equity Boston Scientific Inc (BSX)|EW: Current Liabilities to Equity|Short-Term Debt to Capital RMD (ResMed Inc.)|insulet.com (PODD) - Current Liabilities to Capital|Zimmer Biomet Holdings - Short-Term Debt to Capital|The Cooper Companies, Inc. (COO) - Short-Term Debt to Equity Ratio|ALGN: Short-Term Debt to Capital|GMED - Short-Term Debt to Capital Coefficient|TMDX (TransMedics Group Inc) - Short-Term Debt to Capital|Short-Term Debt to Capital atecspine.com|Short-Term Debt to Equity Enovis (ENOV)|Short-Term Debt to Equity IART (Integra LifeSciences Corp)|Short-Term Debt to Capital ESTA (Motiva)|Short-Term Debt to Capital Coefficient iLet Bionic Pancreas (BBNX)|IRMD: Short-Term Debt to Equity Ratio|Current Liabilities to Equity EMBC|TNDM: Short-Term Debt to Capital|Current Liabilities to Capital AxoGen Inc (AXGN)|SIBN (SI-BONE Corp) - Short-Term Debt to Capital|Short-Term Debt to Capital Ratio OFIX (Orthofix Corp)|Short-Term Debt to Equity Ratio BVS (Bioventus Inc.)|KIDS (orthopediatrics.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Treace Medical Concepts, Inc. TMCI|SRTA - Short-Term Debt to Equity Ratio|Carlsmed Corp - Short-Term Debt to Capital|Current Liabilities to Capital RxSight Ophthalmic|CLPT: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio STXS|STIM (Neuronetics) - Short-Term Debt to Capital|Sight Sciences Inc. (SGHT) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital OBIO|Short-Term Debt to Equity Ratio anikatherapeutics.com ANIK|Short-Term Debt to Capital NSPR (InspireMD, Inc.)|Short-Term Debt to Capital Jin Medical International Ltd. ZJYL|VANI - Short-Term Debt to Equity|XTNT: Short-Term Debt to Equity|NMTC (NeuroOne Corp) - Short-Term Debt to Equity Ratio|Modular Medical, Inc. - Ratio of Short-Term Indebtedness to Capital|MYO (Myomo, Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital envoymedical.com COCH|Short-Term Debt to Equity Vivos Therapeutics, Inc. (VVOS)|enVVeno Medical Corporation (NVNO) - Short-Term Indebtedness to Equity|Sintx Technologies, Inc. - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Tenon Medical Inc TNON|ReWalk Robotics Ltd. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Autonomix Medical, Inc. AMIX|INVO Fertility (IVF) - Short-Term Debt to Equity|Current Liabilities to Equity BBLG (Bone Biologics Corp.)|Short-Term Debt to Equity Axonics Modulation Technologies|Short-Term Debt to Equity Ratio Biolase Inc. (BIOL)|Short-Term Debt to Capital DYNT|FNA - Current Liabilities to Capital|Short-Term Debt to Equity INVO Bioscience INVO